SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sean Janzen who wrote (1408)2/24/2000 9:37:00 PM
From: Bob Schommer  Read Replies (1) of 1501
 
Sean:

I have been long IZP since 1996 and find their prospects now much more compelling than they were back then. The big money is always in the big move; I believe it is ahead and when we look in the rear view mirror it will make 156% look like a paltry sum. There is stagering clinical value to what they are trying to push down the road to market and I am hopeful that the side effect profiles to date enhance the likelihood that these compounds don't end up in the ditch on the way. Progress in Phase II with Apanol should portend a very different valuation toward years end. I don't trade this stock and will not be shaken out of my position until the full tale is told, for good or ill.

Regards,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News